Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and ...
RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s ...
We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...
Today, Benzinga's options scanner identified 8 options transactions for Illumina. This is an unusual occurrence. The ...
In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...
1d
Zacks.com on MSNJAZZ or ILMN: Which Is the Better Value Stock Right Now?Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Illumina (ILMN). But which of these two stocks is more attractive to value ...
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...
Hedge funds and other institutional investors own 89.42% of the company’s stock. Several research firms recently commented on ILMN. Morgan Stanley dropped their price objective on Illumina from ...
TD Cowen analyst Daniel Brennan maintained a Buy rating on NeoGenomics (NEO – Research Report) today and set a price target of $19.00. The company’s shares closed yesterday at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results